A new trading day began on Tuesday, with Zymeworks BC Inc (NASDAQ: ZYME) stock price down -3.01% from the previous day of trading, before settling in for the closing price of $27.62. ZYME’s price has ranged from $9.03 to $28.49 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 15.81% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 40.06%. With a float of $72.91 million, this company’s outstanding shares have now reached $75.14 million.
In an organization with 286 employees, it is important to assess its efficiency.
Zymeworks BC Inc (ZYME) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zymeworks BC Inc is 3.31%, while institutional ownership is 99.50%. The most recent insider transaction that took place on Dec 22 ’25, was worth 1,284,311. In this transaction Chair & CEO of this company sold 47,528 shares at a rate of $27.02, taking the stock ownership to the 133,275 shares. Before that another transaction happened on Dec 22 ’25, when Company’s Officer proposed sale 47,528 for $27.23, making the entire transaction worth $1,294,187.
Zymeworks BC Inc (ZYME) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.31 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.07% during the next five years compared to 15.81% growth over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
Here are Zymeworks BC Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.85, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach 0.57 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Let’s dig in a bit further. During the last 5-days, its volume was 0.74 million. That was better than the volume of 0.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 82.76%.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 89.99%, which indicates a significant increase from 63.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.12 in the past 14 days, which was higher than the 0.88 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.18, while its 200-day Moving Average is $15.52. However, in the short run, Zymeworks BC Inc’s stock first resistance to watch stands at $27.67. Second resistance stands at $28.54. The third major resistance level sits at $29.41. If the price goes on to break the first support level at $25.93, it is likely to go to the next support level at $25.06. Assuming the price breaks the second support level, the third support level stands at $24.19.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
With a market capitalization of 2.02 billion, the company has a total of 74,837K Shares Outstanding. Currently, annual sales are 76,300 K while annual income is -122,700 K. The company’s previous quarter sales were 27,610 K while its latest quarter income was -19,600 K.
